Drug

Enhertu Wins EU Approval in Resected HER2-Positive Breast Cancer – Daiichi Sankyo's ADC Cuts Recurrence Risk by 53% Versus T-DM1
ADC / XDCCancer

Enhertu Wins EU Approval in Resected HER2-Positive Breast Cancer – Daiichi Sankyo’s ADC Cuts Recurrence Risk by 53% Versus T-DM1

Daiichi Sankyo Company, Limited (TYO: 4568) announced that Enhertu (trastuzumab deruxtecan) has been approved for a new indication in the European Union (EU) as a monotherapy for the adjuvant treatment…

Livzon Pharma's LZSN2501 Wins NMPA Clinical Trial Approval for VTE Prevention After Knee Arthroplasty – Bi-Epitopic Bispecific Anti-FXI Antibody Targets Next-Generation Anticoagulation

Livzon Pharma’s LZSN2501 Wins NMPA Clinical Trial Approval for VTE Prevention After Knee Arthroplasty – Bi-Epitopic Bispecific Anti-FXI Antibody Targets Next-Generation Anticoagulation

GeneScience's GenSci136 Wins NMPA Clinical Trial Approval for Sjögren's Syndrome – Proprietary Dual-Target BAFF/APRIL Antagonist Advances Changchun High-Tech's Autoimmune Pipeline

GeneScience’s GenSci136 Wins NMPA Clinical Trial Approval for Sjögren’s Syndrome – Proprietary Dual-Target BAFF/APRIL Antagonist Advances Changchun High-Tech’s Autoimmune Pipeline

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Clinical trial approval / initiationSHE: 002082

Wepon Medical Secures FDA Clinical Approval for WP107 (Huperzine A Oral Solution) in Healthy Volunteers Following NMPA Clearance for Myasthenia Gravis

AstraZenecaCancer

Jacobio Launches Phase Ib/III Trial of Pan-KRAS Inhibitor JAB-23E73 for KRAS-Mutated Pancreatic Cancer in Partnership with AstraZeneca

Clinical trial approval / initiationCSPC Pharmaceutical

CSPC Pharmaceutical Launches Phase III Trial of B7-H3-Targeting ADC SYS 6043 for Platinum-Resistant Ovarian Cancer

Clinical trial approval / initiationCSPC Pharmaceutical

CSPC Pharmaceutical Launches Phase II Trial of Albumin-Bound Sirolimus for Rare Vascular Tumor Epithelioid Hemangioendothelioma

Show More